Combination antiretroviral chemotherapy: A potential strategy in AIDS-related malignancy

Anti-Cancer Drugs

Volumn 7, Issue 1, 1996, Pages 109-113

  Nusbaum, N J ^a   Abraham, T ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AZT (zidovudine); DDC (dideoxycytidine); DDI (didanosine); Hematologic effects; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; DIDANOSINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BONE MARROW TOXICITY; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG EXPOSURE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALIGNANT NEOPLASTIC DISEASE; MODEL; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0029671392     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199601000-00014     Document Type: Article

References (0)